File(s) not publicly available
Plasma concentrations of midazolam during continuous subcutaneous administration in palliative care
journal contributionposted on 2023-05-18, 22:11 authored by Martin BleaselMartin Bleasel, Gregory PetersonGregory Peterson, Dunne, PF
We have investigated the steady-state plasma concentrations of midazolam during continuous subcutaneous administration in palliative care. Using a sensitive gas chromatography with electron capture detector assay, plasma concentrations of midazolam were measured in 11 patients (median age 68 years; range 47-82 years; six females) receiving the drug by continuous subcutaneous infusion (median rate 20 mg/day; range 10-60 mg/day). While not significant, the infusion rate tended to decrease with increasing age of the patient (Spearman's p = -0.51; p = 0.11). The steady-state plasma concentration range was 10-147 ng/ml, with a median of 30 ng/ml. Infusion rates and plasma concentrations of midazolam were correlated (Spearman's p = 0.71; p < 0.05). No other significant relationships were found between plasma concentrations and the variables of age, sex and liver function.
Publication titlePalliative Medicine: A Multiprofessional Journal
Department/SchoolSchool of Pharmacy and Pharmacology
Place of publicationUnited Kingdom